18 April 2019

                          Administering ibuprofen immediately after birth may reduce brain damage in tiny growth-restricted babies, University of Queensland researchers have found.

                          The UQ Centre for Clinical Research’s Dr Julie Wixey said the drug could help reduce the incidence of serious long-term neurological problems in these babies.

                          “It’s often difficult to diagnose babies at risk of being born too small during pregnancy,” Dr Wixey said.

                          “A baby born weighing below the tenth percentile for its gestational age is considered growth-restricted.

                          “These babies didn’t grow enough in the womb because for some reason they didn’t get enough nutrients and oxygen from the placenta.”

                          About 32 million such babies are born around the world each year.

                          Dr Wixey said there were currently no treatments to protect the developing brains of growth-restricted newborns.

                          “We previously found that inflammation is one of the key mechanisms involved in brain injury in growth-restricted babies, so we targeted the inflammation with the common anti-inflammatory drug ibuprofen.

                          “By administering it for three days after birth, we were able to reduce damage to brain cells.”


                          Babies’ brains are vulnerable as they develop, and underdevelopment in the womb can lead to a wide range of long-term problems.

                          “These can range from learning and concentration difficulties through to more serious conditions including cerebral palsy,” Dr Wixey said.

                          She said ibuprofen was already administered to premature babies to treat improperly closed heart valves. 

                          “Since the same dosage is used to treat that condition, we hope to be able to translate the use of ibuprofen to growth-restricted babies following birth.”

                          The research is published in Frontiers in Physiology (DOI 10.3389/fphys.2019.00541). 

                          Media: Dr Julie Wixey, [email protected], +61 7 3346 6027; Faculty of Medicine Communications, [email protected], +61 7 3365 5118. 


                                                                          35选7号码预测 天津时时彩晚上几点停 天涯小阁论坛公式规律 腾讯分分彩杀号计划 江苏时时彩预测软件 112期一肖中平特 山西11选5开奖结果查询结果 时时彩刷大底能赚钱吗 北京快乐8上下盘走势 四川快乐12选5定胆 大乐透除9余数小技巧 3d过滤缩水工具彩宝网 2元彩票群英会 牛牛论坛 河南22选5开奖结果省份